nedosiran

nedosiran · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for nedosiran, covering 2025-07-22 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function [Phase 2]

See pricing